Tag: Cancer: Misc.
ASCO: Adding Daratumumab Early in Myeloma Treatment Efficacious
Response rate doubled for patients with relapsed or refractory multiple myeloma
ASCO: Aggressive Treatment Common in Terminal CA Patients
Three in four of young or middle-aged patients get aggressive therapies in last months of lives
ASCO: Double ASCT Beneficial in High-Risk Neuroblastoma
Tandem treatments might give survival edge to children with neuroblastoma
ASCO: ‘Liquid Biopsy’ Shows Promise for Tumor Surveillance
Guardant360 predicts cancer DNA mutations and could help tailor treatments to avoid drug resistance
15.5 Million Americans Now Surviving Cancer
But better tools needed to support their long-term recovery, researchers say
May 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2016. This roundup includes...
Atrial Fibrillation Linked to Cancer Risk in Women
Women with new-onset AF show elevated cancer risk beyond one year of AF diagnosis
Global Recession Tied to 260,000 Additional Cancer Deaths
Health care cuts, unemployment linked to rise in cancer mortality
Many Americans Have Reservations About Clinical Trials
Only 40 percent had favorable view of these studies, but number rose when they received more info
Many Advanced Cancer Patients Lack Info About Their Disease
Just one in 20 terminally ill people understood their prognosis, researchers say
